Clinical Trial Update: R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of tipifarnib (R115777) in children with Neurofibromatosis Type I and progressive plexiform neurofibromas completed; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• Tipifarnib (tipifarnib)
• ZARNESTRA

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neurofibroma, Plexiform, Neurofibromatosis Type I | Phase 2 | Status: COMPLETED | Results posted: 2012-09-17